These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37439872)

  • 1. Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting.
    Greppmair S; Brinkmann A; Roehr A; Frey O; Hagel S; Dorn C; Marsot A; El-Haffaf I; Zoller M; Saller T; Zander J; Schatz LM; Scharf C; Briegel J; Minichmayr IK; Wicha SG; Liebchen U
    Intensive Care Med; 2023 Aug; 49(8):966-976. PubMed ID: 37439872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    Schatz LM; Brinkmann A; Röhr A; Frey O; Greppmair S; Weinelt F; Zoller M; Scharf C; Hempel G; Liebchen U
    Antimicrob Agents Chemother; 2023 May; 67(5):e0010423. PubMed ID: 37125925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive performance of multi-model approaches for model-informed precision dosing of piperacillin in critically ill patients.
    Schatz LM; Greppmair S; Kunzelmann AK; Starp J; Brinkmann A; Roehr A; Frey O; Hagel S; Dorn C; Zoller M; Scharf C; Wicha SG; Liebchen U
    Int J Antimicrob Agents; 2024 Oct; 64(4):107305. PubMed ID: 39146997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Evaluation of Population Pharmacokinetic Models of Piperacillin in Preterm and Term Patients from Neonatal Intensive Care.
    Boer-Pérez FS; Lima-Rogel V; Mejía-Elizondo AR; Medellín-Garibay SE; Rodríguez-Báez AS; Rodríguez-Pinal CJ; Milán-Segovia RDC; Romano-Moreno S
    Eur J Drug Metab Pharmacokinet; 2024 Sep; 49(5):595-607. PubMed ID: 38951408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.
    Heus A; Uster DW; Grootaert V; Vermeulen N; Somers A; In't Veld DH; Wicha SG; De Cock PA
    Int J Antimicrob Agents; 2022 May; 59(5):106579. PubMed ID: 35341931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients.
    El-Haffaf I; Guilhaumou R; Velly L; Marsot A
    Clin Pharmacokinet; 2022 Jun; 61(6):895-906. PubMed ID: 35344155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
    Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
    Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
    Velarde-Salcedo R; Pérez-González LF; Rodríguez-Báez AS; Arriaga-García FJ; Milán-Segovia RDC; Romano-Moreno S; Medellín-Garibay SE
    Eur J Pediatr; 2023 Sep; 182(9):4143-4152. PubMed ID: 37436522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
    Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
    Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis.
    Selig DJ; DeLuca JP; Chung KK; Pruskowski KA; Livezey JR; Nadeau RJ; Por ED; Akers KS
    J Clin Pharm Ther; 2022 Aug; 47(8):1091-1102. PubMed ID: 35352374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients.
    Verhaeghe J; Dhaese SAM; De Corte T; Vander Mijnsbrugge D; Aardema H; Zijlstra JG; Verstraete AG; Stove V; Colin P; Ongenae F; De Waele JJ; Van Hoecke S
    BMC Med Inform Decis Mak; 2022 Aug; 22(1):224. PubMed ID: 36008808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
    Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
    J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population.
    Duong A; El Gamal A; Bilodeau V; Huot J; Delorme C; Poudrette J; Crevier B; Marsot A
    Pharmacotherapy; 2024 Jun; 44(6):425-434. PubMed ID: 38803279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.
    Felton TW; Roberts JA; Lodise TP; Van Guilder M; Boselli E; Neely MN; Hope WW
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4094-102. PubMed ID: 24798288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
    Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pharmacokinetics software for therapeutic drug monitoring of piperacillin in patients with severe infections.
    Rodríguez-Báez AS; Jiménez-Meseguer M; Milán-Segovia RDC; Romano-Moreno S; Barcia E; Ortiz-Álvarez A; García-Díaz B; Medellín-Garibay SE
    Eur J Hosp Pharm; 2024 Apr; 31(3):201-206. PubMed ID: 36126967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients.
    Cunio CB; Uster DW; Carland JE; Buscher H; Liu Z; Brett J; Stefani M; Jones GRD; Day RO; Wicha SG; Stocker SL
    Clin Microbiol Infect; 2020 Jul; ():. PubMed ID: 32673799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients.
    Yang N; Wang J; Xie Y; Ding J; Wu C; Liu J; Pei Q
    Front Pharmacol; 2022; 13():838205. PubMed ID: 35662716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients.
    Chai MG; Roberts JA; Farkas A; Cotta MO
    J Antimicrob Chemother; 2023 Feb; 78(2):354-358. PubMed ID: 36454242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients.
    Kallee S; Scharf C; Schatz LM; Paal M; Vogeser M; Irlbeck M; Zander J; Zoller M; Liebchen U
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.